Avandia 90% Formulary Acceptance Achieved At One Month Post-Launch - SB
Executive Summary
SmithKline Beecham/Bristol-Myers Squibb's Avandia has been "very quickly embraced" by managed care and is reimbursed by 90% of plans, SmithKline Beecham Chief Operating Officer Jean-Pierre Garnier, PhD, reported Sept. 16 at the Bear Stearns health care conference in New York City.
You may also be interested in...
SmithKline Avandia Recommended Only For Combination Use By CPMP
SmithKline Beecham's thiazolidinedione antidiabetic Avandia is in the final stages of EU approval following a positive recommendation by the Committee for Proprietary Medicinal Products March 16.
SmithKline Avandia Recommended Only For Combination Use By CPMP
SmithKline Beecham's thiazolidinedione antidiabetic Avandia is in the final stages of EU approval following a positive recommendation by the Committee for Proprietary Medicinal Products March 16.
HMR's Arava May Be Ripe For Review By Cigna Soon After 6-Month Delay
Hoechst Marion Roussel's arthritis immunotherapy Arava is likely to be considered for coverage by the large Cigna Healthcare prescription plan, which represents about 1% of total U.S annual drug purchases.